A new drug has been approved by the European Medicines Agency which could offer better treatment to patients with multiple sclerosis. Alemtuzumab will give people who have the disease the chance to live without the side effects for much longer.
Symptoms of the disease can include loss of physical skills, sensation, vision and bladder control.
Professor Herman Waldmann was involved in the early discovery work of the antibody drug called Campath-1H at Cambridge University. It was originally used to treat leukaemia. He continued to study the drug for two decades while at Oxford University.
More top news
Homeowners have been left devastated after a pick up truck smashed into their house and left the scene
12 Clipper Round the World 70ft yachts begin their full circumnavigation from Liverpool today
Philippa has Sunday's weather for the east